CIK 0000906709
- Non-accelerated filer
- Smaller reporting company
NEKTAR THERAPEUTICS
Sign in to watch- Ticker
- NKTR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 943134940
- Phone
- +1 415-482-5300
- Business address
- 455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO, CA, 94158
- Former names
- INHALE THERAPEUTIC SYSTEMS INC, INHALE THERAPEUTIC SYSTEMS
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $22,263
- in 2 filings
Net −$22,263. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2015-12-15 | Nicholson John SVP & Chief Financial Officer | Grant or award · Stock Option | +22,000 | 22,000 | ||
| 2015-12-15 | ROBIN HOWARD W President & CEO | Grant or award · Restricted Stock Unit | +67,500 | 67,500 | ||
| 2015-12-15 | ROBIN HOWARD W President & CEO | Grant or award · Stock Option | +56,250 | 56,250 | ||
| 2015-12-15 | Gergel Ivan P. SVP & Chief Medical Officer | Grant or award · Restricted Stock Unit | +15,000 | 15,000 | ||
| 2015-12-15 | Gergel Ivan P. SVP & Chief Medical Officer | Grant or award · Stock Option | +12,500 | 12,500 | ||
| 2015-12-15 | Doberstein Stephen K SVP & Chief Scientific Officer | Grant or award · Restricted Stock Unit | +10,500 | 10,500 | ||
| 2015-12-15 | Doberstein Stephen K SVP & Chief Scientific Officer | Grant or award · Stock Option | +8,750 | 8,750 | ||
| 2015-12-15 | Thomsen Jillian B. SVP & Chief Accounting Officer | Grant or award · Restricted Stock Unit | +18,750 | 18,750 | ||
| 2015-12-15 | Thomsen Jillian B. SVP & Chief Accounting Officer | Grant or award · Stock Option | +22,500 | 22,500 | ||
| 2015-12-15 | ROBIN HOWARD W President & CEO | Grant or award · Restricted Stock Unit | +56,250 | 56,250 | ||
| 2015-12-15 | ROBIN HOWARD W President & CEO | Grant or award · Stock Option | +67,500 | 67,500 | ||
| 2015-12-15 | Nicholson John SVP & Chief Financial Officer | Grant or award · Restricted Stock Unit | +22,000 | 22,000 | ||
| 2015-12-15 | Nicholson John SVP & Chief Financial Officer | Grant or award · Stock Option | +26,000 | 26,000 | ||
| 2015-12-15 | Labrucherie Gil M SVP & General Counsel | Grant or award · Restricted Stock Unit | +22,000 | 22,000 | ||
| 2015-12-15 | Labrucherie Gil M SVP & General Counsel | Grant or award · Stock Option | +26,000 | 26,000 | ||
| 2015-12-15 | Hora Maninder SVP Pharma Dev & Mfg Ops | Grant or award · Restricted Stock Unit | +22,000 | 22,000 | ||
| 2015-12-15 | Hora Maninder SVP Pharma Dev & Mfg Ops | Grant or award · Stock Option | +26,000 | 26,000 | ||
| 2015-12-15 | Gergel Ivan P. SVP & Chief Medical Officer | Grant or award · Restricted Stock Unit | +12,500 | 12,500 | ||
| 2015-12-15 | Gergel Ivan P. SVP & Chief Medical Officer | Grant or award · Stock Option | +15,000 | 15,000 | ||
| 2015-12-15 | Doberstein Stephen K SVP & Chief Scientific Officer | Grant or award · Restricted Stock Unit | +8,750 | 8,750 |
Page 56 of 69 · 1,361 trades